Federal Register / Vol. 65, No. 236 / Thursday, December 7, 2000 / Notices 76659

for improving the treatment of Type I

and Type II diabetes.

The prospective exclusive license will

be royalty bearing and will comply with

the terms and conditions of 35 U.S.C.

209 and 37 CFR 404.7. This prospective

exclusive license may be granted unless

within sixty (60) days from the date of

this published notice, NIH receives

written evidence and argument that

establishes that the grant of the license

would not be consistent with the

requirements of 35 U.S.C. 209 and 37

CFR 404.7.

Applications for a license (i.e., a

completed ‘‘Application for License to

Public Health Service Inventions’’) in

the indicated exclusive field of use filed

in response to this notice will be treated

as objections to the grant of the

contemplated license. Comments and

objections will not be made available for

public inspection and, to the extent

permitted by law, will not be subject to

disclosure under the Freedom of

Information Act 35 U.S.C. 552.

Dated: November 29, 2000.

Jack Spiegel,

Director, Division of Technology Development

and Transfer, Office of Technology Transfer.

[FR Doc. 00–31217 Filed 12–6–00; 8:45 am]

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Warren Grant Magnuson Clinical

Center; Proposed Collection;

Comment Request; Customer and

Other Partners Satisfaction Surveys

SUMMARY: In compliance with the

requirement of Section 3506(c)(2)(A) of

the Paperwork Reduction Act of 1995

for the opportunity for public comment

on the proposed data collection projects,

the Warren Grant Magnuson Clinical

Center (CC), the National Institutes of

Health, (NIH) will publish periodic

summaries of proposed projects to be

submitted to the Office of Management

and Budget (OMB) for review and

approval.

Proposed Collection

Title: Generic Clearance for

Satisfaction Surveys of Customer and

Other Partners.

Type of Information Collection

Request: Extension (OMB control

number: 0925–0458).

Need and Use of Information

Collection: The information collected in

these surveys will be used by Clinical

Center personnel: (1) To evaluate the

satisfaction of various Clinical Center

customers and other partners with

Clinical Center services; (2) to assist

with the design of modifications of

these services, based on customer input;

(3) to develop new services, based on

customer need; and (4) to evaluate the

satisfaction of various Clinical Center

customers and other partners with

implemented service modifications.

These surveys will almost certainly lead

to quality improvement activities that

will enhance and/or streamline the

Clinical Center’s operations. The major

mechanisms by which the Clinical

Center will request customer input is

through surveys and focus groups. The

surveys will be tailored specifically to

each class of customer and to that class

of customer’s needs. Surveys will either

be collected as written documents, as

faxed documents, mailed electronically

or collected by telephone from

customers. Information gathered from

these surveys of Clinical Center

customers and other partners will be

presented to, and used directly by,

Clinical Center management to enhance

the services and operations of our

organization.

Frequency of Response: The

participants will respond yearly.

Affected public: Individuals and

households; businesses and other for

profit, small businesses and

organizations.

Types of respondents: These surveys

are designed to assess the satisfaction of

the Clinical Center’s major internal and

external customers with the services

provided. These customers include, but

are not limited to, the following groups

of individuals: Clinical Center patients,

family members of Clinical Center

patients, visitors to the Clinical Center,

National Institutes of Health

investigators, NIH intramural

collaborators, private physicians or

organizations who refer patients to the

Clinical center, volunteers, vendors and

collaborating commercial enterprises,

small businesses, regulators, and other

organizations. The annual reporting

burden is as follows:

TABLE 1.—THREE YEAR BURDEN ESTIMATE

Customer Type of survey

Estimated

number

to be

surveyed

Expected

response

rate

(percent)

Time to

complete

survey

(minutes)

Estimated

burden hours

Clinical Center Patients .................................................... Questionnaire ......................

Telephone ...........................

11,100 66 20 2436.6

Family Members of Patients ............................................. Questionnaire/ .....................

Post Card ............................

8500 38 10 533.3

Visitors to the Clinical Center ........................................... Questionnaire/ .....................

Post Card ............................

3500 15 10 87.5

Former physician employees and trainees ...................... Electronic ............................ 650 35 10 38.2

Guest workers/Guest researchers .................................... Electronic ............................ 950 60 22 210

Extramural collaborators ................................................... Electronic ............................ 600 30 15 45

Vendors and Collaborating Commercial Enterprises ....... Questionnaire/ .....................

Fax Back .............................

9500 17 18 475

Professionals and Organizations Referring Patients ....... Fax Back ............................. 9000 30 28 1250

Regulators ........................................................................ Fax Back ............................. 85 82 19 22

Volunteers ........................................................................ Questionnaire ...................... 850 58 28 230

Total (3 Years) ....................................................... ............................................. .................. n=16,812 .................... 5,327.6

Total (1 Year) ......................................................... ............................................. .................. n=5,604 .................... 1,776.0

76660 Federal Register / Vol. 65, No. 236 / Thursday, December 7, 2000 / Notices

Estimated costs to the respondents

consists of their time; time is estimated

using a rate of $10.00 per hour for

patients and the public; $30.00 for

vendors, regulators, organizations and

$55.00 for health care professionals. The

estimated annual costs to respondents

for each year for which the generic

clearance is requested is $24,531

annually. A contract has been let with

a vendor to provide assistance in survey

administration. The estimated annual

cost of this contract is $25,000. There is

no capital costs to report.

Requests for Comments

Written comments and/or suggestions

from the public and affected agencies

are invited on one or more of the

following points: (1) Whether the

proposed collection of information is

necessary for the proper performance of

the functions of the Clinical Center and

the agency, including whether the

information shall have practical utility;

(2) The accuracy of the agency’s

estimate of the burden of the proposed

collection of information, including the

validity of the methodology and

assumptions used; (3) Ways to enhance

the quality, utility, and clarity of the

information to be collected; and (4)

Ways to minimize the burden of the

collection of information on those who

are to respond, including the use of

automated, electronic, mechanical, or

other technological collection

techniques or other forms of information

technology.

FOR FURTHER INFORMATION CONTACT: To

request more information on the

proposed project, to obtain a copy of the

data collection plans and instruments,

or to submit comments, contact: Dr.

David K. Henderson, Deputy Director

for Clinical Care, Warren G. Magnuson

Clinical Center, National Institutes of

Health, Building 10, Room 2C 146, 9000

Rockville Pike, Bethesda, Maryland

20892, or call non-toll free: (301) 496–

3515, or e-mail your request or

comments, including your address to

dhenderson@cc.nih.gov.

Comments Due Date

Comments regarding this information

collection are best assured of having

their full effect if received on or before

February 5, 2001.

Dated: November 18, 2000.

David K. Henderson,

Deputy Director for Clinical Care, CC.

[FR Doc. 00–31214 Filed 12–6–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HOUSING AND

URBAN DEVELOPMENT

[Docket No. FR–4621–N–02]

Community Planning and Development

Formula Programs: Assisting Persons

With Disabilities—Recipients’

Affirmatively Furthering Fair Housing

Responsibilities and Involvement of

Persons With Disabilities in Planning

Actions

AGENCY: Office of the Assistant

Secretary for Community Planning and

Development, and Office of the

Assistant Secretary for Fair Housing and

Equal Opportunity, HUD.

ACTION: Notice.

SUMMARY: The purpose of this notice is

to reemphasize the responsibility of

Community Planning and Development

formula grant program recipients to: (1)

Affirmatively further fair housing which

includes analyzing compliance with the

multifamily design and construction

requirements of the Fair Housing Act

(the Act); and (2) include individuals

with disabilities in the citizen

participation process for the

development of Consolidated Plans and

Annual Action Plans.

FOR FURTHER INFORMATION CONTACT:

Bryan Greene, Office of Fair Housing

and Equal Opportunity, Department of

Housing and Urban Development, 451

Seventh Street, SW, Washington, DC

20410; telephone (202) 708–1145 (this is

not a toll-free number), or Terry Buss,

Office of Community Planning and

Development, Department of Housing

and Urban Development, 451 Seventh

Street, SW, Washington, DC 20410;

telephone (202) 708–2504 (this is not a

toll-free number). Persons with hearing

or speech impairments may access these

numbers via TTY by calling the toll-free

Federal Information Relay Service at 1–

800–877–8339.

SUPPLEMENTARY INFORMATION:

Background

Every three to five years, each State

and local government that is a recipient

of HUD formula grant funds through the

Community Development Block Grant

Program, HOME Investment

Partnerships Program, Housing

Opportunities for Persons With AIDS

Program or the Emergency Shelter Grant

Program must submit a complete

Consolidated Plan that assesses its

priority housing and homeless needs,

including the needs of persons with

disabilities, and establishes a strategic

plan for addressing these needs. (In this

notice, the term ‘‘jurisdictions’’ (or

‘‘jurisdiction’’) refers to States and local

governments that are recipients of this

funding.)

Annually, jurisdictions must submit

the Action Plan component of the

Consolidated Plan which describes how

these funds will be used. When

preparing its Consolidated Plan and its

Action Plans, the jurisdiction must

include the participation of its citizens

in accordance with its citizen

participation plan. The citizen

participation plan must provide for and

encourage citizens to participate in the

development of the Consolidated Plan,

including any substantial amendments

to the Consolidated Plan, and

preparation of the Annual Performance

Report. Jurisdictions are also expected

to take whatever actions are appropriate

to encourage the participation of all its

citizens, including minorities and nonEnglish speaking persons, as well as

persons with disabilities.

In its annual submission to HUD, each

recipient jurisdiction must submit a

certification required by the Community

Development Block Grant regulations

(24 CFR 570.601(a)(2)) and the

Consolidated Plan regulations (24 CFR

91.225(a)(1), 91.325(a)(1) [States] and

91.425(a)(1) [Consortia]) that it will

affirmatively further fair housing. The

jurisdiction’s affirmatively furthering

certification means that the jurisdiction

will conduct an analysis to identify

impediments to fair housing choice

within the jurisdiction, take appropriate

actions to overcome the effects of any

impediments identified through that

analysis, and maintain records reflecting

the analysis and actions taken. If the

jurisdiction is not undertaking these

actions, the Department may reject the

certification and disapprove the

Consolidated Plan.

The analysis of impediments (AI) to

fair housing choice includes an

assessment of conditions, both public

and private, affecting fair housing

choice. The amendments to the Act in

1988 made it unlawful to discriminate

against persons because of disability,

including the failure to make

multifamily residential structures built

for first occupancy after March 13, 1991

accessible to persons with disabilities.

The Act requires that all units in an

elevator building with four or more

units be accessible to persons with

disabilities. In a non-elevator building

with four or more units, all ground floor

units must be accessible to such

persons. These requirements apply

whether the building is privately or

publicly constructed and owned.